Business
Resverlogix Appoints Kenneth J. Zuerblis to Board of Directors
Resverlogix Appoints Kenneth J. Zuerblis to Board of Directors
About this update from Resverlogix Corp.
[{"type":"text","content":"\n\n\n\n Sep. 30, 2010 (Canada NewsWire Group) -- \n\n#ReleaseContent TABLE\n{\n BORDER-COLLAPSE: collapse\n}\nTR.cnwUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px solid\n}\n#ReleaseContent TABLE.cnwBorderedTable TD\n{\n BORDER-RIGHT: black 1px solid;\n PADDING-RIGHT: 2px;\n BORDER-TOP: black 1px solid;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n BORDER-LEFT: black 1px solid;\n PADDING-TOP: 2px;\n BORDER-BOTTOM: black 1px solid;\n BORDER-COLLAPSE: collapse\n}\n#ReleaseContent TABLE TD\n{\n PADDING-RIGHT: 2px;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n PADDING-TOP: 2px\n}\n\nTSX Exchange Symbol: RVX\n\nCALGARY, Sept. 30 /CNW/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announces that Mr. Kenneth Zuerblis has been appointed to the Company's Board of Directors. Recently Mr. Zuerblis served as the Chief Financial Officer and Senior Vice President of ImClone Systems Inc., prior to its acquisition by Eli Lilly.\n"I was initially attracted to Resverlogix because of RVX-208, its novel atherosclerosis drug, which is a very exciting mid-stage therapeutic gaining worldwide scientific acceptance. Resverlogix is also developing a pipeline of novel therapeutics in several disease categories that have significant unmet medical needs. I look forward to this opportunity to work with members of the Board of Directors and management as we develop the full potential of the Company's product candidates," Mr. Zuerblis commented.\nDonald J. McCaffrey, President & CEO of Resverlogix, stated, "Ken is a seasoned veteran in the biotechnology industry with a proven track record of running complex commercial and research organizations and we are delighted that he has joined our Board of Directors." In an effort to maintain a Board of Director level at six people Mr. Wayne Chiu will be stepping down from the Board effective today. Wayne has been on the Board since its inception and has been an important contributor to the growth and development of Resverlo...